Ocugen, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 09/30/23 | FY 06/30/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.4 | $4.1 | $6.0 | — | — |
| Operating income | -$62.9 | -$54.8 | -$65.5 | — | — |
| Net income | -$67.8 | -$54.1 | -$63.1 | — | — |
| Balance Sheet | |||||
| Total debt | $31.5 | $32.5 | — | — | — |
| Cash Flow Statement | |||||
| Free cash flow | -$57.1 | -$45.5 | -$72.5 | — | — |
Shares outstanding 339.1M · Free float 96.1%
Annual filing data through FY ended December 31, 2025; float as of September 28, 2026.